- Report
- May 2025
- 300 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- January 2025
- 250 Pages
Global
From €4623EUR$4,999USD£3,864GBP
- Report
- August 2024
- 150 Pages
Global
From €2579EUR$2,789USD£2,156GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3578EUR$3,869USD£2,991GBP
- Report
- May 2023
- 160 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- May 2023
- 147 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- March 2023
- 147 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- March 2023
- 147 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- May 2023
- 116 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- July 2024
- 139 Pages
Global
From €2312EUR$2,500USD£1,933GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2312EUR$2,500USD£1,933GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1156EUR$1,250USD£966GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- June 2026
- 138 Pages
United Kingdom
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 143 Pages
India
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 148 Pages
Germany
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 143 Pages
Russia
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 143 Pages
China
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 142 Pages
Japan
From €3699EUR$3,999USD£3,091GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €3699EUR$3,999USD£3,091GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more